GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Cash Payments

Asarina Pharma AB (OSTO:ASAP) Cash Payments


View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.


Asarina Pharma AB Business Description

Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65
Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.